BISEGNA, MARIA LAURA
BISEGNA, MARIA LAURA
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
A novel complex mutation in the exon 9 of CALR gene: p.E381fs*52 (gagg_CCTCTTTGCCTC)
2025 Laganà, Alessandro; Ielo, Claudia; Buffolino, Sonia; Di Lascio, Attilio; Bizzoni, Luisa; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Diverio, Daniela; Breccia, Massimo
Asciminib in the treatment of chronic myeloid leukemia in chronic phase
2025 Costa, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Breccia, Massimo
Baseline, Drug‐Related and Persistent Anemia and/or Thrombocytopenia Predict Responses and Prognosis in Myelofibrosis Patients Treated With Ruxolitinib
2025 Laganà, A.; Scalzulli, E.; Carmosino, I.; Bisegna, M. L.; Sorella, S.; Ielo, C.; Zhdanovskaya, N.; Martelli, M.; Breccia, M.
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP
2024 Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP
2024 Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITDmut -AML): a flow-cytometric marker for an accurate diagnostic workup
2025 Laganà, Alessandro; Kasmi, Deborah; Diverio, Daniela; Bisegna, Maria Laura; Carmosino, Ida; Scalzulli, Emilia; Minotti, Clara; Laura Milani, Maria; Buffolino, Sonia; Martelli, Maurizio; Breccia, Massimo; De Propris, Maria Stefania
Clinical and biological advances of critical complications in acute myeloid leukemia
2025 Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Clinical Relevance and Prognostic Value of the Triple A (AAA) Score in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX)
2025 Laganà, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Carmosino, Ida; Ielo, Claudia; Andriola, Costanza; Martelli, Maurizio; Breccia, Massimo
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions
2022 Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Diagnostica di laboratorio e strumentale
2022 Chistolini, Antonio; Fava, Carmen; Saglio, Giuseppe; Giona, Fiorina; Pavan, Laura; Bisegna, MARIA LAURA
Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time
2024 Scalzulli, E.; Costa, A.; Carmosino, I.; Musiu, P.; Bisegna, M. L.; De Propris, M. S.; Ielo, C.; Diverio, D.; Minotti, C.; Capria, S.; Latagliata, R.; Martelli, M.; Breccia, M.
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients
2022 Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.
Increased Rate of Anemia and Discontinuation in Older Patients with Myelofibrosis Treated with Ruxolitinib
2025 Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Ielo, Claudia; Andriola, Costanza; Martelli, Maurizio; Breccia, Massimo
INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS)
2025 Laganà, Alessandro; Maglione, Raffaele; Costa, Alessandro; Mandelli, Biancamaria; Bisegna, Maria Laura; Milani, Maria Laura; Filipponi, Valeria; Nardacci, Maria Grazia; Soriano, Tania; Santacroce, Eugenio; Petrucci, Luigi; Giordano, Carla; Martelli, Maurizio; De Propris, Maria Stefania
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds
2023 Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
2024 Lagana, Alessandro; Passucci, Mauro; Pepe, Sara; Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo
NG2 molecule expression in acute lymphoblastic leukemia B cells: a flow-cytometric marker for the rapid identification of KMT2A gene rearrangements
2024 Bisegna, Maria Laura; Peragine, Nadia; Elia, Loredana; Matarazzo, Mabel; Milani, Maria Laura; Intoppa, Stefania; Di Trani, Mariangela; Malfona, Francesco; Martelli, Maurizio; De Propris, Maria Stefania
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors
2024 Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
POSTER: CML-473 Treatment-Free Remission (TFR) in Chronic-Phase Chronic Myeloid Leukemia (CP-CML): Analysis of Predictive Factors and Novel Scoring System for Molecular Recurrence
2025 Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Ielo, Claudia; Diverio, Daniela; Martelli, Maurizio; Breccia, Massimo
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib
2025 Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria L.; Martelli, Maurizio; Breccia, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A novel complex mutation in the exon 9 of CALR gene: p.E381fs*52 (gagg_CCTCTTTGCCTC) | 2025 | Laganà, Alessandro; Ielo, Claudia; Buffolino, Sonia; Di Lascio, Attilio; Bizzoni, Luisa; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Diverio, Daniela; Breccia, Massimo | |
| Asciminib in the treatment of chronic myeloid leukemia in chronic phase | 2025 | Costa, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Breccia, Massimo | |
| Baseline, Drug‐Related and Persistent Anemia and/or Thrombocytopenia Predict Responses and Prognosis in Myelofibrosis Patients Treated With Ruxolitinib | 2025 | Laganà, A.; Scalzulli, E.; Carmosino, I.; Bisegna, M. L.; Sorella, S.; Ielo, C.; Zhdanovskaya, N.; Martelli, M.; Breccia, M. | |
| CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP | 2024 | Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania | |
| CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP | 2024 | Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania | |
| CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITDmut -AML): a flow-cytometric marker for an accurate diagnostic workup | 2025 | Laganà, Alessandro; Kasmi, Deborah; Diverio, Daniela; Bisegna, Maria Laura; Carmosino, Ida; Scalzulli, Emilia; Minotti, Clara; Laura Milani, Maria; Buffolino, Sonia; Martelli, Maurizio; Breccia, Massimo; De Propris, Maria Stefania | |
| Clinical and biological advances of critical complications in acute myeloid leukemia | 2025 | Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Clinical Relevance and Prognostic Value of the Triple A (AAA) Score in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX) | 2025 | Laganà, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Carmosino, Ida; Ielo, Claudia; Andriola, Costanza; Martelli, Maurizio; Breccia, Massimo | |
| CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions | 2022 | Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Diagnostica di laboratorio e strumentale | 2022 | Chistolini, Antonio; Fava, Carmen; Saglio, Giuseppe; Giona, Fiorina; Pavan, Laura; Bisegna, MARIA LAURA | |
| Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time | 2024 | Scalzulli, E.; Costa, A.; Carmosino, I.; Musiu, P.; Bisegna, M. L.; De Propris, M. S.; Ielo, C.; Diverio, D.; Minotti, C.; Capria, S.; Latagliata, R.; Martelli, M.; Breccia, M. | |
| Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients | 2022 | Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M. | |
| Increased Rate of Anemia and Discontinuation in Older Patients with Myelofibrosis Treated with Ruxolitinib | 2025 | Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Ielo, Claudia; Andriola, Costanza; Martelli, Maurizio; Breccia, Massimo | |
| INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS) | 2025 | Laganà, Alessandro; Maglione, Raffaele; Costa, Alessandro; Mandelli, Biancamaria; Bisegna, Maria Laura; Milani, Maria Laura; Filipponi, Valeria; Nardacci, Maria Grazia; Soriano, Tania; Santacroce, Eugenio; Petrucci, Luigi; Giordano, Carla; Martelli, Maurizio; De Propris, Maria Stefania | |
| Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds | 2023 | Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation | 2024 | Lagana, Alessandro; Passucci, Mauro; Pepe, Sara; Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo | |
| NG2 molecule expression in acute lymphoblastic leukemia B cells: a flow-cytometric marker for the rapid identification of KMT2A gene rearrangements | 2024 | Bisegna, Maria Laura; Peragine, Nadia; Elia, Loredana; Matarazzo, Mabel; Milani, Maria Laura; Intoppa, Stefania; Di Trani, Mariangela; Malfona, Francesco; Martelli, Maurizio; De Propris, Maria Stefania | |
| Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors | 2024 | Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| POSTER: CML-473 Treatment-Free Remission (TFR) in Chronic-Phase Chronic Myeloid Leukemia (CP-CML): Analysis of Predictive Factors and Novel Scoring System for Molecular Recurrence | 2025 | Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Ielo, Claudia; Diverio, Daniela; Martelli, Maurizio; Breccia, Massimo | |
| Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib | 2025 | Laganà, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria L.; Martelli, Maurizio; Breccia, Massimo |